Tough Sell? Pfizer CEO Outlines Lipitor Game Plan For Generic Zocor

Pfizer's efforts to sustain growth for Lipitor in the face of forthcoming competition from generic versions of Merck's Zocor will focus on educating payers about atorvastatin's positive impact on overall healthcare costs relative to simvastatin, CEO Hank McKinnell said Jan. 4